Ola Brodin

2.9k total citations · 1 hit paper
65 papers, 2.2k citations indexed

About

Ola Brodin is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Ola Brodin has authored 65 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Oncology, 28 papers in Pulmonary and Respiratory Medicine and 19 papers in Molecular Biology. Recurrent topics in Ola Brodin's work include Lung Cancer Research Studies (16 papers), Lung Cancer Treatments and Mutations (15 papers) and Lung Cancer Diagnosis and Treatment (7 papers). Ola Brodin is often cited by papers focused on Lung Cancer Research Studies (16 papers), Lung Cancer Treatments and Mutations (15 papers) and Lung Cancer Diagnosis and Treatment (7 papers). Ola Brodin collaborates with scholars based in Sweden, Denmark and United Kingdom. Ola Brodin's co-authors include Michael C. Perry, Jean‐Pierre Pignon, B Lebeau, R Joss, R. Arriagada, David H. Johnson, Henry Wagner, T Onoshi, Martin H.N. Tattersall and Merrill S. Kies and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Cancer.

In The Last Decade

Ola Brodin

63 papers receiving 2.1k citations

Hit Papers

A Meta-Analysis of Thoracic Radiotherapy for Small-Cell L... 1992 2026 2003 2014 1992 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. A Meta-Analysis of Thoracic Radiotherapy for Small-Cell Lung Cancer
    1992 932 citations Ola Brodin et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ola Brodin Sweden 23 1.4k 861 799 671 197 65 2.2k
Thierry Jahan United States 28 1.8k 1.3× 1.8k 2.1× 327 0.4× 680 1.0× 290 1.5× 79 3.5k
Takeshi Isobe Japan 23 897 0.6× 884 1.0× 241 0.3× 696 1.0× 286 1.5× 130 2.2k
Yuxiang Ma China 32 2.2k 1.6× 1.2k 1.4× 386 0.5× 804 1.2× 504 2.6× 166 3.8k
Hiroshi Kagamu Japan 27 1.6k 1.2× 1.0k 1.2× 299 0.4× 534 0.8× 213 1.1× 172 3.0k
Peter Naredi Sweden 29 1.1k 0.8× 274 0.3× 156 0.2× 610 0.9× 221 1.1× 130 2.5k
Yuan Li Shen China 26 805 0.6× 325 0.4× 220 0.3× 657 1.0× 314 1.6× 75 2.6k
Giovanni Rossi Italy 26 790 0.6× 1.0k 1.2× 164 0.2× 442 0.7× 303 1.5× 114 2.3k
Nader Hanna United States 30 1.5k 1.1× 736 0.9× 233 0.3× 804 1.2× 514 2.6× 111 3.0k
T Dyba Italy 11 893 0.6× 642 0.7× 214 0.3× 520 0.8× 356 1.8× 28 2.1k
Robert Carr United Kingdom 25 411 0.3× 578 0.7× 274 0.3× 430 0.6× 154 0.8× 58 2.5k

Countries citing papers authored by Ola Brodin

Since Specialization
Citations

This map shows the geographic impact of Ola Brodin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ola Brodin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ola Brodin more than expected).

Fields of papers citing papers by Ola Brodin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ola Brodin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ola Brodin. The network helps show where Ola Brodin may publish in the future.

Co-authorship network of co-authors of Ola Brodin

This figure shows the co-authorship network connecting the top 25 collaborators of Ola Brodin. A scholar is included among the top collaborators of Ola Brodin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ola Brodin. Ola Brodin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Breuer, Olof, Ola Brodin, Ali Razaghi, et al.. (2023). Intravenous Infusion of High Dose Selenite in End-Stage Cancer Patients: Analysis of Systemic Exposure to Selenite and Seleno-Metabolites. Biomedicines. 11(2). 295–295. 2 indexed citations
2.
Razaghi, Ali, et al.. (2022). Soluble PD-L1 Expression After Intravenous Treatment of Cancer Patients With Selenite in Phase I Clinical Trial. Frontiers in Oncology. 12. 906134–906134. 7 indexed citations
3.
Hedman, M., Thomas Björk‐Eriksson, Ola Brodin, & Iuliana Toma-Daşu. (2013). Predictive value of modelled tumour control probability based on individual measurements ofin vitroradiosensitivity and potential doubling time. British Journal of Radiology. 86(1025). 20130015–20130015. 9 indexed citations
4.
Nyman, Jan, Andreas Hallqvist, Ola Brodin, et al.. (2009). Concurrent cetuximab and radiotherapy after docetaxel-cisplatin induction chemotherapy in stage III NSCLC: a phase II study from the Swedish Lung Cancer Study Group. Journal of Thoracic Oncology. 4(9). 373–373. 1 indexed citations
5.
Björk‐Eriksson, Thomas, et al.. (2009). Comparison of predicted and clinical response to radiotherapy: A radiobiology modelling study. Acta Oncologica. 48(4). 584–590. 11 indexed citations
6.
Selenius, Markus, Aristi P. Fernandes, Ola Brodin, Mikael Björnstedt, & Anna-Klara Rundlöf. (2008). Treatment of lung cancer cells with cytotoxic levels of sodium selenite: Effects on the thioredoxin system. Biochemical Pharmacology. 75(11). 2092–2099. 41 indexed citations
7.
Bergqvist, Michael, Daniel Brattström, Anders Larsson, et al.. (2004). The role of circulating anti-p53 antibodies in patients with advanced non-small cell lung cancer and their correlation to clinical parameters and survival. BMC Cancer. 4(1). 66–66. 17 indexed citations
8.
Brattström, Daniel, Michael Bergqvist, Patrik Hesselius, et al.. (2003). Serum VEGF and bFGF adds prognostic information in patients with normal platelet counts when sampled before, during and after treatment for locally advanced non-small cell lung cancer. Lung Cancer. 43(1). 55–62. 39 indexed citations
9.
Berglund, Åke, Bengt Glimelius, Jonas Bergh, et al.. (2002). Selection of Chemotherapy by Ex Vivo Assessment of Tumor Sensitivity to Cytotoxic Drugs: Results of a Clinical Trial. Medical Oncology. 19(3). 151–160. 8 indexed citations
10.
Brattström, Daniel, Michael Bergqvist, Patrik Hesselius, et al.. (2002). Elevated preoperative serum levels of angiogenic cytokines correlate to larger primary tumours and poorer survival in non-small cell lung cancer patients. Lung Cancer. 37(1). 57–63. 55 indexed citations
11.
Stockeld, Dag, Jan Tennvall, Gunnar Wagenius, et al.. (2001). A Swedish Study of Chemoradiation in Squamous Cell Carcinoma of the Esophagus. Acta Oncologica. 40(5). 566–573. 18 indexed citations
12.
13.
Brattström, Daniel, Michael Bergqvist, Kristina Lamberg, et al.. (1998). Complete sequence of p53 gene in 20 patients with lung cancer: comparison with chemosensitivity and immunohistochemistry. Medical Oncology. 15(4). 255–261. 18 indexed citations
14.
Brattström, Daniel, Mattias Bergqvist, Anders Larsson, et al.. (1997). Basic fibroblast growth factor and vascular fibroblast growth factor measured in sera from patients with non-small cell lung cancer.. Tumor Biology. 18. 3 indexed citations
15.
Brodin, Ola, Nõu E, Claes Mercke, et al.. (1996). Comparison of induction chemotherapy before radiotherapy with radiotherapy only in patients with locally advanced squamous cell carcinoma of the lung. European Journal of Cancer. 32(11). 1893–1900. 32 indexed citations
16.
Nygren, Peter, K Csóka, Bertil Jönsson, et al.. (1995). The cytotoxic activity of Taxol in primary cultures of tumour cells from patients is partly mediated by Cremophor EL. British Journal of Cancer. 71(3). 478–481. 43 indexed citations
17.
18.
Lampic, Claudia, et al.. (1994). Coping, Psychosocial Well-Being and Anxiety in Cancer Patients at Follow-up Visits. Acta Oncologica. 33(8). 887–894. 55 indexed citations
19.
Brodin, Ola, Lena Lennartsson, & Sten Nilsson. (1991). Single-Dose and Fractionated Irradiation of FouR Human Lung Cancer Cell Lines in Vitro. Acta Oncologica. 30(8). 967–974. 24 indexed citations
20.
Brodin, Ola, G. Rikner, Lena Steinholtz, & Nõu E. (1990). Local Failure in Patients Treated with Radiotherapy and Multidrug Chemotherapy for Small Cell Lung Cancer. Acta Oncologica. 29(6). 739–746. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Thierry Jahan Breakdown of academic impact, for papers by Takeshi Isobe Breakdown of academic impact, for papers by Yuxiang Ma Breakdown of academic impact, for papers by Hiroshi Kagamu Breakdown of academic impact, for papers by Peter Naredi Breakdown of academic impact, for papers by Yuan Li Shen Breakdown of academic impact, for papers by Giovanni Rossi Breakdown of academic impact, for papers by Nader Hanna Breakdown of academic impact, for papers by T Dyba Breakdown of academic impact, for papers by Robert Carr
Rankless by CCL
2026